1. Zhou, Jianlin, Qiao, Xi, Xiao, Ling, Zhou, Chang, Zhang, Jian. 2010. Identification and characterization of the novel protein CCDC106 that interacts with p53 and promotes its degradation. In FEBS letters, 584, 1085-90. doi:10.1016/j.febslet.2010.02.031. https://pubmed.ncbi.nlm.nih.gov/20159018/
2. Cao, Canhui, Hong, Ping, Huang, Xingyu, Li, Guoliang, Wu, Peng. 2020. HPV-CCDC106 integration alters local chromosome architecture and hijacks an enhancer by three-dimensional genome structure remodeling in cervical cancer. In Journal of genetics and genomics = Yi chuan xue bao, 47, 437-450. doi:10.1016/j.jgg.2020.05.006. https://pubmed.ncbi.nlm.nih.gov/33023834/
3. Zhang, Xiupeng, Zheng, Qin, Wang, Chen, Qiu, Xueshan, Wang, Enhua. . CCDC106 promotes non-small cell lung cancer cell proliferation. In Oncotarget, 8, 26662-26670. doi:10.18632/oncotarget.15792. https://pubmed.ncbi.nlm.nih.gov/28460455/
4. Su, Xiaoxue, Zhang, Meng, Yang, Guinan, Du, Liunianbo, Pei, Yuanmin. . Bioinformatics and machine learning approaches reveal key genes and underlying molecular mechanisms of atherosclerosis: A review. In Medicine, 103, e38744. doi:10.1097/MD.0000000000038744. https://pubmed.ncbi.nlm.nih.gov/39093811/
5. Ning, Yichong, Wang, Chunqing, Liu, Xin, Zhou, Jianlin, Zhou, Chang. 2019. CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression. In Journal of experimental & clinical cancer research : CR, 38, 131. doi:10.1186/s13046-019-1137-8. https://pubmed.ncbi.nlm.nih.gov/30885251/
智鼠故事 
